Fiche centre
Bradford Royal Infirmary
Bradford — United Kingdom
Essais liés3clinical trials
VilleBradfordlocalisation
PaysUnited Kingdomlocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT02710435
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Survodutide | Maladie coronarienne | Phase 3 | NCT07850063 | ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease | NOT_YET_RECRUITING |
| Reducer System | Maladie coronarienne | À vérifier | NCT02710435 | REDUCER-I: An Observational Study of the Neovasc Reducer™ System | ACTIVE_NOT_RECRUITING |
| Vicadrostat | Hypertension | Phase 3 | NCT07064473 | EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease | RECRUITING |